ArticleEBioMedicine2025

Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas.

Maryam Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.